IXICO announced that Giulio Cerroni will be appointed to the Board as Chief Executive Officer with effect from February 6, 2017. Derek Hill, the co-founder and current CEO, will remain on the board and continue to serve the company as an executive director. Derek will have specific responsibility for deepening the company's relationships with major pharmaceutical companies, key opinion leaders and government agencies as well as advancing the company’s pioneering range of digital technologies. Giulio, has almost 30 years of international management experience gained in life sciences and diagnostics sectors.  He was previously Managing Director of the Genomics division of LGC Group (LGC).